Literature DB >> 20980644

Ruminant-produced trans-fatty acids raise plasma total and small HDL particle concentrations in male Hartley guinea pigs.

Beth H Rice1, Jana Kraft, Frédéric Destaillats, Dale E Bauman, Adam L Lock.   

Abstract

Although trans-fatty acid (tFA) intake has been positively associated with coronary heart disease (CHD), the relative effect of consuming industrially produced (IP)- compared with ruminant-produced (RP)-tFA on CHD risk factors is unclear. This study was designed to examine the effects of feeding partially hydrogenated vegetable oil (PHVO), IP-tFA source, and butter oil (BO), RP-tFA source, on the development of atherosclerosis and risk factors associated with CHD. Forty-eight male Hartley guinea pigs were fed a hypercholesterolemic diet containing (9% by weight) PHVO, BO, coconut oil (CO; positive control), or soybean oil (SO; negative control) for 8 or 12 wk (n = 6/group). Morphological analysis revealed that none of the groups developed atherosclerosis. Plasma and hepatic lipids did not differ between the tFA groups, but total and small HDL particles were significantly higher in the BO group than in the PHVO group and mean HDL particle size was significantly smaller in the BO group than in the PHVO group. Compared with the other treatment groups, the SO treatment resulted in significantly lower total cholesterol (TC) and LDL cholesterol in plasma, whereas hepatic TC was significantly higher in the SO group than in the other treatment groups. Plasma and hepatic cholesterol concentrations did not differ between the tFA and CO treatments. These results demonstrate that when fed at a high dose, IP- and RP-tFA had the same effect on established CHD risk factors in male Hartley guinea pigs. The effects of RP-tFA on HDL particle sizes and concentrations warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980644      PMCID: PMC2981004          DOI: 10.3945/jn.110.127258

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  42 in total

1.  Quantitative analysis of atherosclerotic lesion composition in mice.

Authors:  Marilyn P Wadsworth; Burton E Sobel; David J Schneider; Wendy Tra; Hans van Hirtum; Douglas J Taatjes
Journal:  Methods Mol Biol       Date:  2006

2.  Replacing dietary carbohydrate with protein and fat decreases the concentrations of small LDL and the inflammatory response induced by atherogenic diets in the guinea pig.

Authors:  Matthew J Sharman; Maria Luz Fernandez; Tosca L Zern; Moises Torres-Gonzalez; William J Kraemer; Jeff S Volek
Journal:  J Nutr Biochem       Date:  2008-03-06       Impact factor: 6.048

3.  Soluble fiber and soybean protein reduce atherosclerotic lesions in guinea pigs. Sex and hormonal status determine lesion extension.

Authors:  E Cos; T Ramjiganesh; S Roy; S Yoganathan; R J Nicolosi; M L Fernandez
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

4.  trans fatty acids and systemic inflammation in heart failure.

Authors:  Dariush Mozaffarian; Eric B Rimm; Irena B King; Richard L Lawler; George B McDonald; Wayne C Levy
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.

Authors:  A H Lichtenstein; L M Ausman; S M Jalbert; E J Schaefer
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

6.  Intake of ruminant trans fatty acids and risk of coronary heart disease.

Authors:  Marianne U Jakobsen; Kim Overvad; Jørn Dyerberg; Berit L Heitmann
Journal:  Int J Epidemiol       Date:  2007-12-12       Impact factor: 7.196

7.  Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs.

Authors:  Moises Torres-Gonzalez; Jose O Leite; Jeff S Volek; John H Contois; Maria Luz Fernandez
Journal:  J Nutr Biochem       Date:  2008-05-20       Impact factor: 6.048

8.  Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study.

Authors:  Lewis Kuller; Alice Arnold; Russell Tracy; James Otvos; Greg Burke; Bruce Psaty; David Siscovick; David S Freedman; Richard Kronmal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-07-01       Impact factor: 8.311

9.  Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects.

Authors:  R P Mensink; M B Katan
Journal:  N Engl J Med       Date:  1990-08-16       Impact factor: 91.245

10.  Ruminant and industrially produced trans fatty acids: health aspects.

Authors:  Steen Stender; Arne Astrup; Jørn Dyerberg
Journal:  Food Nutr Res       Date:  2008-03-12       Impact factor: 3.894

View more
  4 in total

1.  Ruminant-produced trans-fatty acids raise plasma HDL particle concentrations in intact and ovariectomized female Hartley guinea pigs.

Authors:  Beth H Rice; Jana Kraft; Frédéric Destaillats; Dale E Bauman; Adam L Lock
Journal:  J Nutr       Date:  2012-07-18       Impact factor: 4.798

Review 2.  Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies.

Authors:  Sarah K Gebauer; Jean-Michel Chardigny; Marianne Uhre Jakobsen; Benoît Lamarche; Adam L Lock; Spencer D Proctor; David J Baer
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

3.  9c11tCLA modulates 11t18:1 and 9t18:1 induced inflammations differently in human umbilical vein endothelial cells.

Authors:  Jing Li; Sheng-Ben Hu; Yue-Ming He; Cheng-Fei Zhuo; Ruo-Lin Zhou; Fang Chen; Hong-Yan Li; Ze-Yuan Deng
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

4.  Plasma concentration of cis9trans11 CLA in males and females is influenced by SCD1 genetic variations and hormonal contraceptives: a cross-sectional study.

Authors:  Salma A Abdelmagid; Shannon E Clarke; Jeremy Wong; Kaitlin Roke; Daiva Nielsen; Alaa Badawi; Ahmed El-Sohemy; David M Mutch; David Wl Ma
Journal:  Nutr Metab (Lond)       Date:  2013-07-18       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.